
Trinity Biotech plc TRIB
$ 0.79
2.81%
Annual report 2023
added 02-15-2025
Country |
![]() |
IPO year |
1992 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Brendan Farrell |
Employees in the company |
579 |
Shares |
- |
Market Cap[1] |
$ 61.9 M |
EBITDA (LTM) |
$ 3.56 M |
P/E (LTM) |
0.15 |
P/S (LTM) |
0.43 |
EPS (LTM) |
6.9 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.